BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 03, 2011
 |  BC Week In Review  |  Company News  |  Deals

Emisphere, Novo Nordisk deal

Novo Nordisk received an exclusive license to use Emisphere's Eligen drug delivery technology to develop and commercialize oral formulations of Novo Nordisk's...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >